Literature DB >> 434988

Clonidine and propranolol paradoxical hypertension.

S E Warren, E Ebert, A H Swerdlin, S M Steinberg, R Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 434988     DOI： 10.1001/archinte.139.2.253

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.

Authors:  T Rosenthal; B Rabinowitz; H Boichis; E Elazar; A Brauner; H N Neufeld
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 3.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Long-term experience with the combination of clonidine and beta-adrenoceptor blocking agents in hypertension.

Authors:  R Vanholder; N Lameire; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.